HVN:ASXHarvey Norman Holdings Ltd Analysis
Data as of 2026-06-14 - not real-time
A$4.79
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Harvey Norman (HVN) is trading at AUD 4.79, comfortably above its 20‑day (4.5) and 50‑day (4.55) SMAs but still below the 200‑day SMA (6.21), indicating short‑term momentum amid a longer‑term bearish backdrop. The RSI sits at 63.6, suggesting the stock is approaching overbought territory, while a bullish MACD (line above signal, positive histogram) hints at a possible technical rebound toward the nearby resistance at 4.795. Volume is increasing and volatility remains high at 25% over the past 30 days, underscoring a lively but risky trading environment.
Fundamentally, HVN delivers solid profitability (operating margin 26.5%, profit margin 18.1%) and a robust dividend yield of 6.05% with a 59% payout ratio, supported by healthy free cash flow. Valuation metrics appear attractive: a trailing PE of 10.6, PB of 1.22 and a DCF‑derived fair value of roughly AUD 11.4 suggest the stock is undervalued, with analyst target prices implying about a 10% upside. Recent analyst sentiment highlights the dividend appeal, and market commentary notes that the recent slide to year‑low levels could present a buying opportunity for income‑focused investors.
Fundamentally, HVN delivers solid profitability (operating margin 26.5%, profit margin 18.1%) and a robust dividend yield of 6.05% with a 59% payout ratio, supported by healthy free cash flow. Valuation metrics appear attractive: a trailing PE of 10.6, PB of 1.22 and a DCF‑derived fair value of roughly AUD 11.4 suggest the stock is undervalued, with analyst target prices implying about a 10% upside. Recent analyst sentiment highlights the dividend appeal, and market commentary notes that the recent slide to year‑low levels could present a buying opportunity for income‑focused investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price is perched at the immediate resistance level of 4.795
- Overall trend flagged as bearish despite bullish MACD
- Rising volume coupled with high 30‑day volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervaluation relative to DCF fair value and analyst targets
- Attractive 6.05% dividend yield with sustainable payout
- Bullish MACD momentum supporting a move toward the 5.2‑5.3 target range
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Strong cash generation and low beta indicating defensive characteristics
- Long‑term value upside implied by fair‑value estimate of AUD 11.4
- Consistent profitability and dividend growth potential in the consumer‑cyclical sector
Key Metrics & Analysis
Financial Health
Revenue Growth11.60%
Profit Margin18.13%
P/E Ratio10.6
ROE11.78%
ROA5.77%
Debt/Equity49.80
P/B Ratio1.2
Op. Cash FlowA$639.1M
Free Cash FlowA$755.8M
Technical Analysis
TrendBearish
RSI63.6
SupportA$4.28
ResistanceA$4.80
MA 20A$4.50
MA 50A$4.54
MA 200A$6.21
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueA$11.41
Target PriceA$5.28
Upside/Downside10.21%
GradeUndervalued
TypeValue
Dividend Yield6.05%
Risk Assessment
Beta0.48
Volatility25.41%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.